Arnnon Geshuri - Oct 30, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF PEOPLE OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Oct 30, 2023
Transactions value $
-$5,943
Form type
4
Date filed
11/1/2023, 04:06 PM
Previous filing
Sep 6, 2023
Next filing
Nov 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1.06K +1.39% 77.5K Oct 30, 2023 Direct F1
transaction TDOC Common Stock Sale -$5.94K -365 -0.47% $16.28 77.1K Oct 31, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -1.06K -100% $0.00* 0 Oct 30, 2023 Common Stock 1.06K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit award.
F3 On October 30, 2020, the reporting person was granted 3,181 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.